Calmodulin Kinase Inhibition Prevents Development of the Arrhythmogenic Transient Inward Current
Overview
Authors
Affiliations
Although it is widely accepted that afterdepolarizations initiate arrhythmias when action potentials are prolonged, the underlying mechanisms are unclear. In this study, we tested the hypothesis that action potential prolongation would raise intracellular calcium and thereby activate the arrhythmogenic transient inward current (Iti). Furthermore, given that Iti can be activated by sarcoplasmic reticulum Ca2+ release, we tested the hypothesis that inhibition of calmodulin (CaM) kinase would prevent Iti. Isolated rabbit ventricular myocytes were studied with whole-cell-mode voltage clamp. Stimulation with a prolonged action potential clamp, under near-physiological conditions, increased [Ca2+]i. Iti was reproducibly induced in 60 of 60 cells, but Iti was not seen with the use of a shorter action potential waveform (n=12). Iti was associated with a secondary elevation in [Ca2+]i. When [Ca2+]i buffering was enhanced by dialysis with BAPTA (20 mmol/L, n=9), no Iti was present. The Na+/Ca2+ exchanger was likely responsible for Iti, because Iti was inhibited by the Na+/Ca2+ exchanger inhibitory peptide XIP (10 micromol/L, n=6), but not by an inactive scrambled peptide (10 micromol/L, n=5) or by the Cl- current antagonist niflumic acid (10 to 40 micromol/L, n=9). Activator Ca2+ from the sarcoplasmic reticulum was essential for development of Iti, because it was prevented by pretreatment with ryanodine (10 micromol/L, n=6) or thapsigargin (1 micromol/L, n=6). Two different CaM kinase inhibitory peptides (n=16) and a CaM inhibitory peptide (n=4) completely suppressed Iti. These results are consistent with the hypothesis that CaM kinase plays a role in arrhythmias related to increased [Ca2+]i.
CaMKII as a Therapeutic Target in Cardiovascular Disease.
Reyes Gaido O, Nkashama L, Schole K, Wang Q, Umapathi P, Mesubi O Annu Rev Pharmacol Toxicol. 2022; 63:249-272.
PMID: 35973713 PMC: 11019858. DOI: 10.1146/annurev-pharmtox-051421-111814.
Tran C, Atanasovska T, Graff C, Melgaard J, Kanters J, Smith R Eur J Appl Physiol. 2022; 122(3):691-702.
PMID: 35048183 DOI: 10.1007/s00421-021-04870-7.
CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy.
Veitch C, Power A, Erickson J Front Pharmacol. 2021; 12:695401.
PMID: 34381362 PMC: 8350113. DOI: 10.3389/fphar.2021.695401.
Mesubi O, Rokita A, Abrol N, Wu Y, Chen B, Wang Q J Clin Invest. 2020; 131(2).
PMID: 33151911 PMC: 7810480. DOI: 10.1172/JCI95747.
Role of Oxidative Stress in the Genesis of Ventricular Arrhythmias.
Adameova A, Shah A, Dhalla N Int J Mol Sci. 2020; 21(12).
PMID: 32545595 PMC: 7349053. DOI: 10.3390/ijms21124200.